Cite
RAI16 maintains intestinal homeostasis and inhibits NLRP3‐dependent IL‐18/CXCL16‐induced colitis and the progression of colitis‐associated colorectal cancer
MLA
Wen Wang, et al. “RAI16 Maintains Intestinal Homeostasis and Inhibits NLRP3‐dependent IL‐18/CXCL16‐induced Colitis and the Progression of Colitis‐associated Colorectal Cancer.” Clinical and Translational Medicine, vol. 12, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.1002/ctm2.993.
APA
Wen Wang, Cui‐Ling Ding, Meng‐Xue Wu, Wen Guo, Ran Hu, Yan Liu, Zhong‐Tian Qi, & Xin‐Ming Jia. (2022). RAI16 maintains intestinal homeostasis and inhibits NLRP3‐dependent IL‐18/CXCL16‐induced colitis and the progression of colitis‐associated colorectal cancer. Clinical and Translational Medicine, 12(8). https://doi.org/10.1002/ctm2.993
Chicago
Wen Wang, Cui‐Ling Ding, Meng‐Xue Wu, Wen Guo, Ran Hu, Yan Liu, Zhong‐Tian Qi, and Xin‐Ming Jia. 2022. “RAI16 Maintains Intestinal Homeostasis and Inhibits NLRP3‐dependent IL‐18/CXCL16‐induced Colitis and the Progression of Colitis‐associated Colorectal Cancer.” Clinical and Translational Medicine 12 (8). doi:10.1002/ctm2.993.